Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02351804Phase 2Completed
Phase 2, randomised, double-blind trial in pain comparing Ropivacaine + dexamethasone with Ropivacaine + placebo (2 arms). Primary endpoint: Difference in duration of sensory block between dexamethasone and placebo assessed as cold sensation with an alcohol swab. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02351804.